欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
IT/H/0234/002
药品名称
Rixil
活性成分
valsartan 160.0 mg
剂型
Capsule, hard
上市许可持有人
Novartis Farma S.P.A. Largo Umberto Boccioni 1 210410 Origgio (Varese) Italia
参考成员国 - 产品名称
Italy (IT)
互认成员国 - 产品名称
Greece (GR)
Sweden (SE)
Germany (DE)
Denmark (DK)
Belgium (BE)
Netherlands (NL)
Luxembourg (LU)
Iceland (IS)
United Kingdom (Northern Ireland) (XI)
Ireland (IE)
Austria (AT)
France (FR)
Spain (ES)
Portugal (PT)
Norway (NO)
Finland (FI)
Poland (PL)
Latvia (LV)
Lithuania (LT)
Estonia (EE)
Hungary (HU)
Bulgaria (BG)
Cyprus (CY)
Czechia (CZ)
Romania (RO)
Slovakia (SK)
Slovenia (SI)
Malta (MT)
许可日期
2010/11/05
最近更新日期
2015/05/26
药物ATC编码
C09CA03 valsartan
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase